Asia Executives To Watch: Betta CEO Quits To Nurture Drug Startups

Betta CEO Yinxiang Wang is moving on to focus on a drug discovery incubator while another board director, Zai Lab's Samantha Du, has also resigned. Executive changes are also underway at Japanese drug startup PeptiDream.

chess

More from Executives On The Move

More from Leadership